Size of OLE and length of treatment. I think it is underappreciated how difficult it is to retain elderly patients in a long term trial. Only 30% of 80 year old patients can expect to live another 5 years. The OLE trial was smaller than the main trial but...that is normal, unfortunately.
Market Data 
Markets 
AI
